CAVALLARO, FRANCESCA
CAVALLARO, FRANCESCA
Universita' degli Studi di MILANO
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
2022 M. Manzoni, A. Bosi, S. Fabris, M. Lionetti, S. Salerio, A.C. Migliorini, F. Cavallaro, K. Barbullushi, N. Rampi, V. Montefusco, M.G. Alessio, A. Neri, L. Baldini, M. Sciumè, E. Tagliaferri, N. Fracchiolla, N. Bolli
Recent insights into the role of the microbiome in malignant and benign hematologic diseases
2021 B. Fattizzo, F. Cavallaro, F. Folino, W. Barcellini
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
2021 D. Cattaneo, C. Bucelli, F. Cavallaro, D. Consonni, A. Iurlo
Infectious complications in autoimmune hemolytic anemia
2021 J.A. Giannotta, B. Fattizzo, F. Cavallaro, W. Barcellini
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 B. Fattizzo, J.A. Giannotta, W. Barcellini, M.C. Barbanti, C. Bucelli, R. Cassin, D. Cattaneo, F. Cavallaro, V. Ferla, N.S. Fracchiolla, A. Freyrie, G. Galassi, M.C. Goldaniga, F.I. Grifoni, A. Iurlo, G. Mangiameli, V. Mattiello, M. Meli, A. Neri, A. Noto, F. Onida, L. Ottani, R. Pasquale, L. Pettine, A. Pompa, G. Reda, F.G. Rossi, G.N. Saporiti, M. Sciumè, E. Tagliaferri, L. Baldini
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag
2019 B. Fattizzo, F. Cavallaro, G. Milesi, W. Barcellini
Low-dose rituximab in autoimmune hemolytic anemia : 10 years after
2019 B. Fattizzo, A. Zaninoni, L. Pettine, F. Cavallaro, E. Di Bona, W. Barcellini
Butyric acid: pharmacological aspects and routes of administration
2007 L. Spina, F. Cavallaro, N.I. Fardowza, P. Lagoussis, D. Bona, C. Ciscato, A. Rigante, M. Vecchi